(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEROVEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MEROVEN

ST13

US500000087796085

Class

5, 10, 40

Filing

87796085

Registration

5665056

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

12/09/2025

Trademark type

Combined

Nice classes

5, 10, 40

Filing date

02/13/2018

Registration date

01/29/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

12/09/2025

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Dublin 2 D02 DK18, IE

Examiner

DINALLO,KEVIN M

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a curling ribbon of the colors purple, pink, red, yellow and orange with the wording "MEROVEN" in black stylized lower-case letters to the right of the ribbon.

Holders and representatives

Holders

Meroven Limited

Representatives

Michael A. Marrero UB Greensfelder LLP

Technical classification

Nice Classes

Class 5Class 10Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals and medical preparations and substances for treatment of dermatological conditionspsoriasiserectile dysfunctionhair lossurological conditionsbladder painprostate pain syndromegynecological conditionsendometriosisrecurrent pregnancy lossvaginitisosteoporosisvitamin B12 deficienciesfor fertility purposesoncological conditionschronic myeloid leukemiabladder cancerfor whitening and rejuvenating the skinfor hormone replacement therapy; nasal sprays for medical purposes; decongestant nasal sprays; nasal rinse; suppositories; oral vaccine preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of diseases and disorders of the immune system; pharmaceutical preparations for the treatment of the immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treating and preventing diabetes; anti-infective antibiotics; anti-infective preparations; anti-infective products for veterinary use; anti-allergy sprays; anti-allergy preparations; pain relief preparations; pain relief medication; pain relief creams; acetaminophen; anti-inflammatory preparations; anti-inflammatory sprays and gels; anti-inflammatory ointment; pharmaceutical preparations and substances with anti-inflammatory properties; antipyretics preparations analgesics; pharmaceutical preparations and substances with antipyretics properties; pharmaceutical preparations and substances for use in urology; compounds for treating correlated pulmonary syndromes; pharmaceutical preparations and substances for use in the field of anaesthesia; hormones for medical purposes; oestrogen preparations; hormone suppressing preparations; hormone replacement preparations and substances; sanitary preparations for medical purposes; dietetic food and substances adapted for veterinary usefood for babies; medical plasters being materials for dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; medicines for adjusting the menstrual cycle; topical analgesics; topical analgesics creams; topical anaesthetics

Class 10

Surgical apparatus and instruments; medical apparatus and instruments for vaginal tightening by ablation; dental apparatus for orthodontic correction; orthopaedic articles for treatment of diseases and conditions related to vitamin D deficiencies; suture materials; medical cutting devices; medical instrumentsfor use in general surgery; electro medical instrumentsinstruments for use in tightening the vagina for surgical ablation; medical devices for placing and securing catheters; optical instruments for medical endoscopy; laser instruments for medical use; medical instruments for cutting tissue; dialysis machines for medical use; medical instruments for therapeutic drug monitoring; medical instruments for recording physiological data; cell culture instruments for medical use; medical instruments for infectious disease testing ; impulse measuring instruments for medical use; medical instruments for drug abuse testing; medical instruments for application on human bodiesinstruments for orthodontic correction; laser light treatment instruments for medical use

Class 40

Custom manufacture of medical devices; custom assembling of electronic components for medical devices

Publications

History of USPTO decisions and trademark events.

33 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/18/2025

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/18/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

11/15/2025

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

11/14/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/14/2025

E815

TEAS SECTION 8 & 15 RECEIVED

07/28/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/29/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/29/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/13/2018

PUBO

PUBLISHED FOR OPPOSITION

11/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/24/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/05/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/04/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/03/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/03/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/02/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/01/2018

GNRT

NON-FINAL ACTION E-MAILED

10/01/2018

CNRT

NON-FINAL ACTION WRITTEN

10/01/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/28/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/27/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/27/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/04/2018

GNRT

NON-FINAL ACTION E-MAILED

06/04/2018

CNRT

NON-FINAL ACTION WRITTEN

06/04/2018

DOCK

ASSIGNED TO EXAMINER

05/29/2018

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

03/21/2018

ALIE

ASSIGNED TO LIE

03/18/2018

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

03/06/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/23/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/22/2018

NWAP

NEW APPLICATION ENTERED

02/16/2018

Continuous trademark protection

Get notified about every new filing that threatens MEROVEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.